Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

535
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
535
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

545
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
545
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

812
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
812
Pulmonary Function Tests01:25

Pulmonary Function Tests

543
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
543
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.8K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.8K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

2.9K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Airway wall thickness and PRISm are associated with cognitive impairment in individuals with cigarette smoking exposure.

Respiratory research·2026
Same author

Clinical neuropsychological evaluation of patients referred from a post-COVID subspeciality clinic.

The Clinical neuropsychologist·2026
Same author

Bronchovascular texture pattern on quantitative CT reveals airway and vascular remodeling in post-COVID-19 Lungs.

Respiratory research·2026
Same author

Association of "Emptying Emphysema" with Clinical and Radiographic Features in People with Smoking History.

Annals of the American Thoracic Society·2026
Same author

Association Between Chronic PM2.5 Exposure and CT-Detected Lung Abnormalities in the SPIROMICS Cohort.

Annals of the American Thoracic Society·2026
Same author

Single-cell Sequencing Unveils A Profibrotic Macrophage and Infiltrating Monocyte Niche in the Bronchoalveolar Lavage of Patients with Chronic Obstructive Pulmonary Disease.

American journal of respiratory and critical care medicine·2026

Related Experiment Video

Updated: Nov 18, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

41.1K

Inhaled Medication Use in Smokers With Normal Spirometry.

Nicholas R Arnold1, Emily S Wan2,3, Craig P Hersh2

  • 1Department of Internal Medicine, Division of General Internal Medicine, University of Iowa Roy J. and Lucille A. Carver College of Medicine, Iowa City, Iowa.

Respiratory Care
|February 10, 2021
PubMed
Summary
This summary is machine-generated.

Smokers with normal spirometry using inhaled medications, often due to symptoms or emphysema, were more likely to develop obstructive lung disease. This suggests early identification of potential COPD is possible before formal diagnosis.

Keywords:
COPDempiric treatmentrespiratory function testssmokingspirometry

More Related Videos

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
10:37

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Published on: January 16, 2015

13.5K
Employing the Forced Oscillation Technique for the Assessment of Respiratory Mechanics in Adults
06:11

Employing the Forced Oscillation Technique for the Assessment of Respiratory Mechanics in Adults

Published on: February 9, 2022

6.0K

Related Experiment Videos

Last Updated: Nov 18, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

41.1K
Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
10:37

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Published on: January 16, 2015

13.5K
Employing the Forced Oscillation Technique for the Assessment of Respiratory Mechanics in Adults
06:11

Employing the Forced Oscillation Technique for the Assessment of Respiratory Mechanics in Adults

Published on: February 9, 2022

6.0K

Area of Science:

  • Pulmonology
  • Respiratory Medicine
  • Clinical Epidemiology

Background:

  • Identifying factors associated with inhaled medication use in smokers with normal spirometry (GOLD-0) is crucial.
  • Understanding the link between inhaled medication use and future respiratory outcomes is important for early intervention.

Purpose of the Study:

  • To identify variables linked to inhaled medication use in smokers with normal spirometry.
  • To investigate the association of inhaled medication use with future exacerbations and obstructive spirometry.

Main Methods:

  • Retrospective multivariable analysis of GOLD-0 subjects from the COPDGene study.
  • Categorization of medication use: none, short-acting bronchodilator, long-acting bronchodilator, ICS with or without LBD, and dual bronchodilator with ICS.
  • Evaluation of long-acting inhaled medication use association with exacerbations and obstructive spirometry at 5-year follow-up.

Main Results:

  • 12.6% of GOLD-0 subjects used inhaled medications; 6% used long-acting and 6.6% short-acting bronchodilators.
  • Factors associated with use included female sex, comorbidities, emphysema, chronic bronchitis, dyspnea, asthma history, prior exacerbations, and reduced 6-min walk distance.
  • Inhaled medication use predicted increased respiratory exacerbations and development of obstructive spirometry at follow-up.

Conclusions:

  • Respiratory symptoms, asthma history, and radiographic emphysema are associated with inhaled medication use in smokers with normal spirometry.
  • Inhaled medication use in this group predicts future obstructive spirometry, suggesting potential for early identification of obstructive lung disease.
  • Healthcare providers may identify obstructive lung disease in smokers before they meet current COPD criteria.